Kite catches tailwind on Amgen deal

Kite Pharma Inc. (NASDAQ:KITE) jumped $9.14 (15%) to $69.75 on Monday after Amgen Inc. (NASDAQ:AMGN) agreed

Read the full 168 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE